Pharmacology and Toxicology
-
Discovery of Triple Inhibitors of Both SARS-CoV-2 Proteases and Human Cathepsin L
This article has 11 authors:Reviewed by ScreenIT
-
Oral Lisinopril Raises Tissue Levels of ACE2, the SARS-CoV-2 Receptor, in Healthy Male and Female Mice
This article has 4 authors:Reviewed by ScreenIT
-
AUG-3387, a Human-Derived Monoclonal Antibody Neutralizes SARS-CoV-2 Variants and Reduces Viral Load from Therapeutic Treatment of Hamsters In Vivo
This article has 15 authors:Reviewed by ScreenIT
-
A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
This article has 16 authors:Reviewed by ScreenIT
-
Pyronaridine Protects Against SARS-CoV-2 in Mouse
This article has 20 authors:Reviewed by ScreenIT
-
Development of a novel, pan-variant aerosol intervention for COVID-19
This article has 25 authors:Reviewed by ScreenIT
-
In silico, in vitro screening of plant extracts for anti-SARS-CoV-2 activity and evaluation of their acute and sub-acute toxicity
This article has 5 authors:Reviewed by ScreenIT
-
Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays
This article has 10 authors:Reviewed by ScreenIT
-
Woodsmoke particulates alter expression of antiviral host response genes in human nasal epithelial cells infected with SARS-CoV-2 in a sex-dependent manner
This article has 6 authors:Reviewed by ScreenIT
-
A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related Diseases
This article has 19 authors:Reviewed by ScreenIT